Compile Data Set for Download or QSAR
maximum 50k data
Found 193 with Last Name = 'nambu' and Initial = 'md'
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50327904(2-amino-4-methyl-6-(1H-pyrazol-3-yl)-8-(tetrahydro...)
Affinity DataKi:  0.800nMAssay Description:Inhibition of mTORMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50327907(CHEMBL1257295 | trans-2-amino-8-(4-hydroxycyclohex...)
Affinity DataKi:  0.850nMAssay Description:Inhibition of mTORMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50327894(2-amino-8-isopropyl-6-(6-methoxypyridin-3-yl)-4-me...)
Affinity DataKi:  5nMAssay Description:Inhibition of mTORMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50327906(2-amino-4-methyl-6-(6-methylpyridin-3-yl)-8-(tetra...)
Affinity DataKi:  5nMAssay Description:Inhibition of mTORMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50327903(CHEMBL1258910 | trans-2-amino-8-(4-(2-hydroxyethox...)
Affinity DataKi:  5.11nMAssay Description:Inhibition of mTORMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50327897(2-amino-8-isopropyl-4-methyl-6-(1H-pyrazol-5-yl)pt...)
Affinity DataKi:  6nMAssay Description:Inhibition of mTORMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50327905(CHEMBL1257177 | trans-2-amino-8-((1r,4r)-4-hydroxy...)
Affinity DataKi:  6.80nMAssay Description:Inhibition of mTORMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50327896(2-amino-4-methyl-8-(1-methylethyl)-6-(1H-pyrazol-4...)
Affinity DataKi:  9nMAssay Description:Inhibition of mTORMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50327901(2-amino-8-isopropyl-6-(2-methoxypyrimidin-5-yl)-4-...)
Affinity DataKi:  18nMAssay Description:Inhibition of mTORMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50327900(2-amino-8-isopropyl-6-(6-methoxypyridin-3-yl)-4-me...)
Affinity DataKi:  30nMAssay Description:Inhibition of mTORMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50327898(2-amino-8-isopropyl-4-methyl-6-(1H-1,2,3-triazol-5...)
Affinity DataKi:  113nMAssay Description:Inhibition of mTORMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50327902(2-amino-8-isopropyl-6-(2-methoxypyridin-4-yl)-4-me...)
Affinity DataKi:  947nMAssay Description:Inhibition of mTORMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50327899(2-amino-8-isopropyl-6-(2-methoxypyridin-3-yl)-4-me...)
Affinity DataKi:  3.94E+3nMAssay Description:Inhibition of mTORMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50327895(2-amino-8-isopropyl-4-methoxy-6-(6-methoxypyridin-...)
Affinity DataKi: >4.00E+3nMAssay Description:Inhibition of mTORMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM113428(US8633204, 127)
Affinity DataIC50:  0.480nMpH: 7.4 T: 2°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM50433038(CHEMBL2375957 | US8633204, 299)
Affinity DataIC50:  0.686nMpH: 7.4 T: 2°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM113443(US8633204, 146)
Affinity DataIC50:  0.731nMpH: 7.4 T: 2°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM113420(US8633204, 115)
Affinity DataIC50:  0.75nMpH: 7.4 T: 2°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM113542(US8633204, 276)
Affinity DataIC50:  0.788nMpH: 7.4 T: 2°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM113434(US8633204, 137)
Affinity DataIC50:  0.989nMpH: 7.4 T: 2°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM113441(US8633204, 144)
Affinity DataIC50:  1.01nMpH: 7.4 T: 2°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM113437(US8633204, 140)
Affinity DataIC50:  1.03nMpH: 7.4 T: 2°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM113479(US8633204, 191)
Affinity DataIC50:  1.10nMpH: 7.4 T: 2°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM113453(US8633204, 163)
Affinity DataIC50:  1.20nMpH: 7.4 T: 2°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM113455(US8633204, 165)
Affinity DataIC50:  1.20nMpH: 7.4 T: 2°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM113448(US8633204, 158)
Affinity DataIC50:  1.30nMpH: 7.4 T: 2°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM113544(US8633204, 278)
Affinity DataIC50:  1.30nMpH: 7.4 T: 2°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM113535(US8633204, 265)
Affinity DataIC50:  1.43nMpH: 7.4 T: 2°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM113551(US8633204, 288)
Affinity DataIC50:  1.44nMpH: 7.4 T: 2°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM113417(US8633204, 108)
Affinity DataIC50:  1.57nMpH: 7.4 T: 2°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM50433044(CHEMBL2375963 | US8633204, 304)
Affinity DataIC50:  1.58nMpH: 7.4 T: 2°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM113543(US8633204, 277)
Affinity DataIC50:  1.59nMpH: 7.4 T: 2°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM113469(US8633204, 180)
Affinity DataIC50:  1.60nMpH: 7.4 T: 2°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM113495(US8633204, 217)
Affinity DataIC50:  1.60nMpH: 7.4 T: 2°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM113461(US8633204, 171)
Affinity DataIC50:  1.60nMpH: 7.4 T: 2°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM113526(US8633204, 254)
Affinity DataIC50:  1.70nMpH: 7.4 T: 2°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM113432(US8633204, 135)
Affinity DataIC50:  1.77nMpH: 7.4 T: 2°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM113541(US8633204, 274)
Affinity DataIC50:  1.80nMpH: 7.4 T: 2°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM113527(US8633204, 255)
Affinity DataIC50:  2nMpH: 7.4 T: 2°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM113489(US8633204, 207)
Affinity DataIC50:  2nMpH: 7.4 T: 2°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM113571(US8633204, 318)
Affinity DataIC50:  2.14nMpH: 7.4 T: 2°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM113536(US8633204, 266)
Affinity DataIC50:  2.20nMpH: 7.4 T: 2°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM113550(US8633204, 287)
Affinity DataIC50:  2.20nMpH: 7.4 T: 2°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM113490(US8633204, 210)
Affinity DataIC50:  2.30nMpH: 7.4 T: 2°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM113540(US8633204, 273)
Affinity DataIC50:  2.30nMpH: 7.4 T: 2°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM113467(US8633204, 177)
Affinity DataIC50:  2.40nMpH: 7.4 T: 2°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM113557(US8633204, 294)
Affinity DataIC50:  2.60nMpH: 7.4 T: 2°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM113477(US8633204, 189)
Affinity DataIC50:  2.70nMpH: 7.4 T: 2°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM113499(US8633204, 221)
Affinity DataIC50:  2.80nMpH: 7.4 T: 2°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM113545(US8633204, 279)
Affinity DataIC50:  2.90nMpH: 7.4 T: 2°CAssay Description:Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...More data for this Ligand-Target Pair
In DepthDetails US Patent
Displayed 1 to 50 (of 193 total ) | Next | Last >>
Jump to: